StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) bonds

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$0
$0 due within a year
Net debt
-$120.79M
After $120.79M of cash
Implied interest rate
9.69%
FY2025 interest ÷ average debt
Interest coverage
35.8×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in MiMedx's 10-Q for the period ended Jul 29, 2026

MiMedx's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Citizens Credit Agreement$10.00M$0
Hayfin Loan Agreement Term Loan$300.00M$17.83M

See a number that looks wrong?